ask="N/A"
ask_size="N/A"
average_daily_volume="20555"
bid="13.00"
bid_size="5000"
book_value="6.83"
change="-0.01"
change_from_200_day_moving_average="-0.70"
change_from_50_day_moving_average="-0.28"
change_from_52_week_high="-3.74"
change_From_52_week_low="4.40"
change_in_percent="-0.07%"
close="14.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.99"
ebitda="-31.36M"
eps_estimate_current_year="-2.17"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-2.96"
ex_dividend_date="N/A"
float_shares="7120000"
high="14.15"
high_52_weeks="17.77"
last_trade_date="2/8/2017"
last_trade_price="14.03"
last_trade_size="854"
last_trade_time="4:00pm"
low="13.74"
low_52_weeks="9.63"
market_capitalization="293.38M"
moving_average_200_day="14.73"
moving_average_50_day="14.31"
name="Corvus Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="24.75"
open="13.99"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-4.72%"
percent_change_from_50_day_moving_average="-1.94%"
percent_change_from_52_week_high="-21.04%"
percent_change_from_52_week_low="+45.69%"
previous_close="14.04"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.05"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="20911000"
short_ratio="8.32"
stock_exchange="NGM"
symbol="CRVS"
volume="8837"
weeks_range_52="9.63 - 17.77"
